KR20140076571A - 급성 신장 손상의 조기 모니터링, 진단 및/또는 예후 방법 - Google Patents

급성 신장 손상의 조기 모니터링, 진단 및/또는 예후 방법 Download PDF

Info

Publication number
KR20140076571A
KR20140076571A KR1020147009382A KR20147009382A KR20140076571A KR 20140076571 A KR20140076571 A KR 20140076571A KR 1020147009382 A KR1020147009382 A KR 1020147009382A KR 20147009382 A KR20147009382 A KR 20147009382A KR 20140076571 A KR20140076571 A KR 20140076571A
Authority
KR
South Korea
Prior art keywords
antibody
aquaporin
exosome
ngal
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020147009382A
Other languages
English (en)
Korean (ko)
Inventor
카를로스 에르네스토 이라라자발 무노즈
Original Assignee
유니버시다드 데 로스 안데스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47913944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20140076571(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 유니버시다드 데 로스 안데스 filed Critical 유니버시다드 데 로스 안데스
Publication of KR20140076571A publication Critical patent/KR20140076571A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
KR1020147009382A 2011-09-22 2011-09-22 급성 신장 손상의 조기 모니터링, 진단 및/또는 예후 방법 Withdrawn KR20140076571A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2011/054187 WO2013041913A1 (en) 2011-09-22 2011-09-22 Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage

Publications (1)

Publication Number Publication Date
KR20140076571A true KR20140076571A (ko) 2014-06-20

Family

ID=47913944

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147009382A Withdrawn KR20140076571A (ko) 2011-09-22 2011-09-22 급성 신장 손상의 조기 모니터링, 진단 및/또는 예후 방법

Country Status (15)

Country Link
US (1) US20140329334A1 (cg-RX-API-DMAC7.html)
EP (1) EP2758774A4 (cg-RX-API-DMAC7.html)
JP (1) JP5893742B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140076571A (cg-RX-API-DMAC7.html)
CN (1) CN103917869A (cg-RX-API-DMAC7.html)
AU (1) AU2011377379A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014006741A2 (cg-RX-API-DMAC7.html)
CA (1) CA2849577A1 (cg-RX-API-DMAC7.html)
HK (1) HK1199754A1 (cg-RX-API-DMAC7.html)
IL (1) IL231626A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN03194A (cg-RX-API-DMAC7.html)
MX (1) MX2014003422A (cg-RX-API-DMAC7.html)
PH (1) PH12014500650A1 (cg-RX-API-DMAC7.html)
RU (1) RU2014115999A (cg-RX-API-DMAC7.html)
WO (1) WO2013041913A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016140388A1 (ko) * 2015-03-05 2016-09-09 경북대학교 산학협력단 엑소좀 또는 이의 단백질을 포함하는 장기 독성 진단용 바이오마커 조성물 및 이를 이용한 진단 방법
WO2024085722A1 (ko) * 2022-10-20 2024-04-25 건국대학교 산학협력단 신장 질환의 조기 진단을 위한 바이오마커 조성물 및 이를 이용한 신장 질환의 조기 진단에 필요한 정보를 제공하는 방법
WO2025005733A1 (ko) * 2023-06-30 2025-01-02 연세대학교 산학협력단 급성신손상의 회복에 대한 정보 제공 방법 및 이를 이용한 키트

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014182330A1 (en) 2013-05-06 2014-11-13 Hitachi Chemical Company Ltd Devices and methods for capturing target molecules
FR3014198B1 (fr) * 2013-12-03 2017-03-03 Biomerieux Sa Procede d'isolement d'exosomes
WO2016011383A1 (en) * 2014-07-17 2016-01-21 The Trustees Of The University Of Pennsylvania Methods for using exosomes to monitor transplanted organ status
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
EP3218724A4 (en) * 2014-11-11 2018-08-22 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2016077537A1 (en) * 2014-11-12 2016-05-19 Hitachi Chemical Co., Ltd. Method and device for diagnosing organ injury
US20160320390A1 (en) * 2015-05-01 2016-11-03 Morehouse School Of Medicine Compositions and methods for capturing exosomes
EP3334498B1 (en) 2015-08-12 2023-06-07 The Trustees of Columbia University in the City of New York Methods of treating volume depletion and kidney injury
WO2017040520A1 (en) 2015-08-31 2017-03-09 Hitachi Chemical Co., Ltd. Molecular methods for assessing urothelial disease
JP6531987B2 (ja) * 2015-10-01 2019-06-19 国立大学法人名古屋大学 腎疾患診断のためのエクソソーム回収法
CN105441578B (zh) * 2016-01-19 2018-08-31 中南大学湘雅二医院 尿液外泌体microRNA分子标志物的应用及制备的试剂盒
WO2017155894A1 (en) 2016-03-07 2017-09-14 Cfgenome, Llc Noninvasive molecular controls
CN106053811A (zh) * 2016-06-05 2016-10-26 浙江大学 一种尿液外泌体elisa的检测方法及其应用
RU2647327C2 (ru) * 2016-07-05 2018-03-15 Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО КубГМУ Минздрава России) Способ ранней диагностики хронической болезни почек у пациентов с хронической обструктивной болезнью легких
JP2019168223A (ja) * 2016-08-12 2019-10-03 公立大学法人和歌山県立医科大学 エクソソームの膜に存在するタンパク質の検出方法
CN109425742A (zh) * 2017-08-23 2019-03-05 迪亚莱博（张家港）生物科技有限公司 一种化学发光法快速检测水通道蛋白1的试剂盒
JPWO2019045049A1 (ja) * 2017-09-01 2020-12-03 学校法人帝京大学 腎尿細管細胞特異的発現ベクター
RU2702023C1 (ru) * 2018-08-17 2019-10-04 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики острого повреждения почек после органосохраняющего хирургического лечения локализованного рака почки
ES2968898T3 (es) * 2019-06-06 2024-05-14 Fundacion Instituto De Investig Sanitaria Fundacion Jimenez Diaz Método in vitro para detectar enfermedad renal
EP3904883A1 (en) * 2020-04-07 2021-11-03 Sciomics GmbH Prediction and early diagnosis of acute kidney injury
RU2765678C1 (ru) * 2020-12-21 2022-02-01 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ прогнозирования риска развития острого повреждения почек у больных с острым коронарным синдромом
CN113189321B (zh) * 2021-04-12 2024-06-25 攸太科技(台州)有限公司 一种尿液检测方法
CN116883739A (zh) * 2023-07-10 2023-10-13 中国医学科学院生物医学工程研究所 一种基于图像识别的尿隐血分类方法和系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
WO2004013152A2 (en) * 2002-08-06 2004-02-12 Duke University Novel targets for lithium therapy
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
WO2007127848A1 (en) * 2006-04-26 2007-11-08 University Of Louisville Research Foundation, Inc Isolation of membrane vesicles from biological fluids and methods of using same
KR101970908B1 (ko) * 2008-02-01 2019-04-19 더 제너럴 하스피탈 코포레이션 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
US20110124519A1 (en) * 2008-03-18 2011-05-26 Frank Walter Falkenberg Method of assessing kidney function in a human subject
US7897356B2 (en) * 2008-11-12 2011-03-01 Caris Life Sciences Methods and systems of using exosomes for determining phenotypes
US8394606B2 (en) * 2008-11-05 2013-03-12 Abbott Laboratories Neutrophil gelatinase-associated lipocalin (NGAL) protein isoforms enriched from urine and recombinant chinese hamster ovary (CHO) cells and related compositions, antibodies, and methods of enrichment, analysis and use
CA2744434C (en) * 2008-11-21 2017-10-03 Phadia Ab Methods, devices and kits for detecting or monitoring acute kidney injury
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
WO2010135334A1 (en) * 2009-05-18 2010-11-25 Washington University Methods of renal cancer detection

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016140388A1 (ko) * 2015-03-05 2016-09-09 경북대학교 산학협력단 엑소좀 또는 이의 단백질을 포함하는 장기 독성 진단용 바이오마커 조성물 및 이를 이용한 진단 방법
WO2024085722A1 (ko) * 2022-10-20 2024-04-25 건국대학교 산학협력단 신장 질환의 조기 진단을 위한 바이오마커 조성물 및 이를 이용한 신장 질환의 조기 진단에 필요한 정보를 제공하는 방법
WO2025005733A1 (ko) * 2023-06-30 2025-01-02 연세대학교 산학협력단 급성신손상의 회복에 대한 정보 제공 방법 및 이를 이용한 키트

Also Published As

Publication number Publication date
EP2758774A1 (en) 2014-07-30
US20140329334A1 (en) 2014-11-06
IL231626A0 (en) 2014-05-28
PH12014500650A1 (en) 2014-06-02
AU2011377379A1 (en) 2014-04-10
WO2013041913A1 (en) 2013-03-28
JP5893742B2 (ja) 2016-03-23
CA2849577A1 (en) 2013-03-28
MX2014003422A (es) 2014-10-13
HK1199754A1 (en) 2015-07-17
BR112014006741A2 (pt) 2017-03-28
CN103917869A (zh) 2014-07-09
EP2758774A4 (en) 2015-04-29
IN2014DN03194A (cg-RX-API-DMAC7.html) 2015-05-22
RU2014115999A (ru) 2015-10-27
JP2014528076A (ja) 2014-10-23

Similar Documents

Publication Publication Date Title
KR20140076571A (ko) 급성 신장 손상의 조기 모니터링, 진단 및/또는 예후 방법
US20140200184A1 (en) Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury
Mussap et al. Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology
Naguib et al. Serum level of the autophagy biomarker Beclin-1 in patients with diabetic kidney disease
US8592170B2 (en) High molecular weight Ngal as a biomarker for chronic kidney disease
Rogulska et al. The most promising biomarkers of allogeneic kidney transplant rejection
RU2733471C2 (ru) Способ прогнозирования риска развития хронического заболевания почек
US20150044695A1 (en) Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
Kanda et al. An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions
Younes-Ibrahim Biomarkers and kidney diseases: a brief narrative review
Peng et al. Comparison of biomarkers in rat renal ischemia-reperfusion injury
Chen et al. Clinical value of the sTim-3 level in chronic kidney disease
KR101686877B1 (ko) GDF15 발현 수준을 측정하는 제제를 포함하는 IgA 신병증 진단 또는 예후 분석용 키트
KR20250062590A (ko) 신장 이식 후 만성거부반응 진단용 조성물
Ghys Investigation of cystatin C for the detection of feline chronic kidney disease
US20150064715A1 (en) Urinary biomarkers of renal and mitochondrial dysfunction
Lin New methods of detecting kidney disease biomarkers in biofluids
Asya et al. Expression Profiles of CLDN2, CLDN14, and CaSR Genes in Idiopathic Calcium Oxalate Kidney Stones Patients of South Panjab, Pakistan
Twumasi et al. Neutrophil gelatinase-associated lipocalin and fibrinogen-to-albumin ratio are indicators of kidney disease in sickle cell disease patients with microalbuminuria: a multicentre case-control study in Ghana
Żywiec et al. Analysis of relationship between UMOD polymorphisms rs13335818, rs4293393 and rs13333226 and risk of chronic kidney disease caused by chronic glomerulonephritis
Simic-Ogrizovic et al. Risk factors associated with coronary artery calcification should be examined before kidney transplantation
WO2016186173A1 (ja) 劇症肝不全の診断方法、及び予防又は治療剤
Mussap et al. Laboratory medicine for the evaluation of kidney disease: from the fetus to the adult
Liberek et al. Sp151renal amyloidosis–a common cause of nephrotic syndrome in older patients
CN112147329A (zh) Atp柠檬酸裂解酶作为脓毒症诊断标志物的用途

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140409

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid